-Reuters
Glaxo, SK Bioscience Start COVID-19 Vaccine Trial Against AstraZeneca Shot
GlaxoSmithKline Plc (NYSE:GSK) has started Phase 3 clinical study for a COVID-19 vaccine candidate designed by South Korean drugmaker SK Bioscience Co.…
Related Posts
Boehringer Ingelheim And BiomX Collaborate To Discover Inflammatory Bowel Disease Microbiome Biomarkers
BiomX's XMarker biomarker discovery platform to potentially inform Boehringer Ingelheim's development of IBD therapeutics
Marks the second agreement between Boehringer Ingelheim and BiomX focused on IBD
BiomX
Hot AI Trading Platform Offers Tools To Stay on Track
Capital.com, a safe and cutting edge trading platform, is opening the door to the crypto market, granting international traders access to upcoming Initial Public Offerings (IPO) and Contracts for Difference (CFD) on 3,000 markets ranging from Bitcoin to Apple (NYSE: AAPL) to gold.
Home Depot Beats On Q2 Aided By Home Improvement Project Demand; Reaffirms FY22 Guidance
Home improvement retailer Home Depot Inc (NYSE:HD) reported second-quarter FY22 sales growth of 6.5% year-on-year to $43.79 billion, beating the consensus of…